Addex Therapeutics Ltd (ADXN) — Long-term Investment Intensity
Addex Therapeutics Ltd (ADXN) has a Long-term Investment Intensity of 60.2% as of September 2025. Long-term investments of CHF4.41 Million represent 60.2% of total assets of CHF7.33 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See ADXN net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Addex Therapeutics Ltd Long-term Investment Intensity (2024–2024)
This chart shows how Addex Therapeutics Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2024 to 2024. As of September 2025, the intensity stands at 60.2%, reflecting long-term investments of CHF4.41 Million against total assets of CHF7.33 Million CHF. Also explore ADXN asset base for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Addex Therapeutics Ltd (2024–2024)
The table below presents the year-by-year Long-term Investment Intensity for Addex Therapeutics Ltd from 2024 to 2024, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market value of Addex Therapeutics Ltd.
| Year | LT Investment Intensity | LT Investments (CHF) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 66.4% | CHF7.09 Million | CHF10.67 Million | — |